Phase-3 clinical trial of India's first dengue vaccine begins at KIMS-Bhubaneswar
3 months, 3 weeks ago

Phase-3 clinical trial of India's first dengue vaccine begins at KIMS-Bhubaneswar

New Indian Express  

BHUBANESWAR: The phase-3 clinical trial for India's first Indigenous dengue vaccine, ‘DengiAll,’ commenced at the Kalinga Institute of Medical Sciences on Tuesday. This trial aims to evaluate the efficacy of the Indigenous tetravalent dengue vaccine developed by Panacea Biotec in collaboration with the Indian Council of Medical Research. The tetravalent dengue vaccine, originally developed by the National Institutes of Health, USA, has shown promising results in preclinical and clinical trials worldwide. “We have to recruit more than 500 participants in Bhubaneswar who would volunteer for the third phase trial,” said a vaccine investigator involved in the process.

India Dengue Bhubaneswar Kims Phase Trial Vaccine Begins  phase3  kimsbhubaneswar  indias  trials  panacea  vaccine  begins  phase  trial  dengue  clinical  tetravalent  process  promising

History of this topic

Major milestone for India’s dengue shot as Phase 3 trials begin
4 months, 1 week ago

Major milestone for India’s dengue shot as Phase 3 trials begin

Hindustan Times  

The Indian Council of Medical Research and Panacea Biotec announced on Wednesday that they have started the first-ever Phase 3 clinical trial for its anti-dengue vaccine candidate in India; the country currently does not have an approved vaccine for the illness. The global incidence of dengue has been steadily increasing over the past two decades, with at least 129 countries …

ICMR and Panacea Biotec begin Phase 3 clinical trial of India’s 1st indigenous dengue vaccine DengiAll
4 months, 1 week ago

ICMR and Panacea Biotec begin Phase 3 clinical trial of India’s 1st indigenous dengue vaccine DengiAll

Live Mint  

The Indian Council of Medical Research and Panacea Biotec on Wednesday announced the commencement of the Phase 3 clinical trial of India's first indigenous dengue vaccine, DengiAll, at Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences Rohtak. Union Health Minister JP Nadda hailed the initiative, stating, “The initiation of this Phase 3 clinical trial for India's first indigenous …

ICMR, Panacea Biotec Initiate First Dengue Vaccine Phase-3 Clinical Trial in India
4 months, 1 week ago

ICMR, Panacea Biotec Initiate First Dengue Vaccine Phase-3 Clinical Trial in India

Deccan Chronicle  

Hyderabad: The Indian Council of Medical Research and Panacea Biotec have announced the initiation of the first-ever Phase-III clinical trial for a dengue vaccine in India. This landmark trial will evaluate the efficacy of India’s indigenous tetravalent dengue vaccine, DengiAll, developed by Panacea Biotec. Commenting on this milestone, Union Minister of Health and Family Welfare J.P. Nadda, said, “The initiation …

ICMR, Panacea Biotec begin first-ever phase 3 clinical trial of made-in-India dengue vaccine
4 months, 1 week ago

ICMR, Panacea Biotec begin first-ever phase 3 clinical trial of made-in-India dengue vaccine

New Indian Express  

NEW DELHI: In a significant announcement, the centre on Wednesday said that the first-ever Phase 3 clinical trial for a made-in-India dengue vaccine has been initiated. The Indian Council of Medical Research and Panacea Biotec have announced the initiation of this landmark trial, which will evaluate the efficacy of India’s indigenous tetravalent dengue vaccine, DengiAll, developed by Panacea Biotec. The …

WHO prequalifies second dengue vaccine: Know all about it
7 months, 1 week ago

WHO prequalifies second dengue vaccine: Know all about it

India Today  

The World Health Organisation has prequalified a second vaccine for dengue, made by the Japanese drug maker Takeda Pharmaceuticals. Known as TAK-003, it is a live-attenuated vaccine containing weakened versions of the four serotypes of the virus that cause dengue. This means that the TAK-003 contains weakened forms of the four types of dengue virus, helping the body to build …

UN agency authorizes second vaccine against dengue amid outbreaks in the Americas
7 months, 1 week ago

UN agency authorizes second vaccine against dengue amid outbreaks in the Americas

New Indian Express  

GENEVA: The World Health Organization on Wednesday authorized a second dengue vaccine, a move that could provide protection for millions worldwide against the mosquito-borne disease that has already sparked numerous outbreaks across the Americas this year. In a statement on Wednesday, the UN health agency said it approved the dengue vaccine made by the Japanese pharmaceutical Takeda, recommending its use …

Hyderabad’s Biological E. to make 50 million doses of Takeda’s dengue vaccine
9 months, 3 weeks ago

Hyderabad’s Biological E. to make 50 million doses of Takeda’s dengue vaccine

The Hindu  

Takeda and Hyderabad-based vaccine maker Biological E. have formed a strategic partnership to accelerate access to the Japanese biopharmaceutical major’s QDENGA dengue vaccine multi-dose vials. BE will ramp up to a manufacturing capacity of up to 50 million doses a year, accelerating Takeda’s efforts to manufacture 100 million doses a year within the decade, the firms said on their partnership …

ICMR considers developing vaccine against Nipah
1 year, 3 months ago

ICMR considers developing vaccine against Nipah

Hindustan Times  

The Indian Council of Medical Research is considering developing a vaccine against the Nipah virus, as part of a larger plan to develop a bouquet of essential vaccines. “Our biggest asset at the moment is that we have developed vaccines on diverse platforms such -- DNA vaccine, mRNA vaccine, adenoviral vector vaccine, protein subunit vaccine, and nasal vaccine -- and …

Dengue vaccine: India moves closer to getting its first indigenous vaccine
1 year, 7 months ago

Dengue vaccine: India moves closer to getting its first indigenous vaccine

The Hindu  

Moving closer to being able to develop the country’s first vaccine against dengue, drug-makers Serum Institute of India and Panacea Biotec have applied to the Indian Council of Medical Research’s call for ‘Expression of Interest’ for collaborative Phase-III clinical trials for indigenous manufacturers. Phase-III clinical trial is being done for evaluation of efficacy, along with safety and immunogenicity of tetravalent …

COVID-19 intranasal vaccine Phase III trials over, proven safe, says Bharat Biotech
2 years, 4 months ago

COVID-19 intranasal vaccine Phase III trials over, proven safe, says Bharat Biotech

Deccan Chronicle  

HYDERABAD: Bharat Biotech International Limited on Monday said its COVID-19 intranasal vaccine has proven to be safe, well-tolerated, and immunogenic in subjects in controlled clinical trials phase III. Product development related to pre-clinical safety evaluation, large-scale manufacturing scale-up, formulation, and delivery device development, including human clinical trials, was conducted by Bharat Biotech. Suchitra K Ella, Joint Managing Director, Bharat Biotech, …

Defanging Dengue: India Moving A Step Closer in Achieving Its First Vaccine for Dreaded Disease
2 years, 7 months ago

Defanging Dengue: India Moving A Step Closer in Achieving Its First Vaccine for Dreaded Disease

News 18  

The country’s first vaccine for dengue is now getting a step closer, as the Indian Council of Medical Research is planning to submit the clinical trial protocol to the nation’s drug regulator by June, News18.com has learnt. “Trials may start by October this year.” Role of ICMR in dengue vaccine project According to the expression of interest floated by ICMR, …

Drug to Cure Dengue Likely in 5 Years as Government Looks to Find Solutions
2 years, 10 months ago

Drug to Cure Dengue Likely in 5 Years as Government Looks to Find Solutions

News 18  

An affordable, safe and effective treatment for dengue, a disease that kills several in India each year, might be on the cards with a matter of years. The Transitional Health Science and Technology Institute, an autonomous institute of the Centre-backed department of biotechnology under the ministry of science and technology has partnered with non-profit research institute Drugs for Neglected Diseases …

Indian scientists working on 1st ever dengue DNA vaccine
3 years, 2 months ago

Indian scientists working on 1st ever dengue DNA vaccine

Hindustan Times  

The world’s first DNA vaccine was approved for use in India recently. Now, some researchers believe the technology -- considered superior because DNA vaccines are easier to make and store, and, most importantly store an enormous amount of information -- can be used to develop a vaccine for another tropical disease, dengue, a viral infection transmitted by mosquitoes. With the …

4 Covid vaccine candidates in trial stage, 1 in pre-clinical stage: Govt
3 years, 5 months ago

4 Covid vaccine candidates in trial stage, 1 in pre-clinical stage: Govt

Live Mint  

As many as four coronavirus vaccine candidates are at different stages of human trials while one, developed by Genique Life Sciences, is in the advanced pre-clinical stage, Jitendra Singh, Union Science and Technology Minister, said in the Rajya Sabha on Tuesday. The Union Minister said that Cadila Healthcare Ltd's DNA-based Covid-19 vaccine candidate is in phase three clinical trial. In …

Politics drives India's fight against the COVID-19 pandemic even as questions over DCGI's approvals for vaccines persist
3 years, 11 months ago

Politics drives India's fight against the COVID-19 pandemic even as questions over DCGI's approvals for vaccines persist

The Hindu  

The Drug Controller General ofIndia’s rushed approval on January 3 for Restricted Emergency Use —also sometimes referred to as Emergency Use Authorisation —of two COVID-19 vaccines— Covishield of the Serum Institute of India, Pune, and Covaxin of Bharat Biotech, Hyderabad—has revealed once again that politics and not science continues to be in the driving seat in the fight against the …

Over 100 Experts from Friendly Nations Trained for Clinical Trials of Indian Covid-19 Vaccine: Official
4 years ago

Over 100 Experts from Friendly Nations Trained for Clinical Trials of Indian Covid-19 Vaccine: Official

News 18  

Over 100 experts from friendly neighbouring nations have so far been trained to strengthen capacities in their countries for facilitating phase-3 clinical trials of Indian COVID-19 vaccine, a senior official of the department of biotechnology said on Wednesday. Addressing a webinar organised by the Confederation of Indian Industry, Alka Sharma, an adviser with the Department of Biotechnology, said the partnership …

Coronavirus | Foreign envoys visit Bharat Biotech, Biological E vaccine facilities in Hyderabad
4 years ago

Coronavirus | Foreign envoys visit Bharat Biotech, Biological E vaccine facilities in Hyderabad

The Hindu  

A delegation of foreign envoys visited manufacturing facilities of vaccine makers Bharat Biotech and Biological E in Hyderabad’s Genome Valley on Wednesday as part a visit to familiarise them with the work underway for Covid-19 vaccines. Bharat Biotech said a team comprising Ambassadors, High Commissioners and government representatives of 70 countries, from across the world, visited the facility and had …

Covid vaccine update: India gears up for phase 3 trials of Oxford, Russian candidates
4 years, 3 months ago

Covid vaccine update: India gears up for phase 3 trials of Oxford, Russian candidates

India Today  

India is moving full steam ahead with advanced stage trials of leading Covid vaccine candidates from around the world. The Health Ministry on Tuesday said that while Phase 2-3 trials for the Oxford and Bharat Biotech vaccine candidates will begin as early as next week, India will also be starting trials for Russia's Sputnik V vaccine. The Oxford vaccine, being …

Covid-19: Serum Institute of India Gets Nod for Phase 2, 3 Clinical Trials of Oxford Vaccine Candidate on Adults
4 years, 4 months ago

Covid-19: Serum Institute of India Gets Nod for Phase 2, 3 Clinical Trials of Oxford Vaccine Candidate on Adults

News 18  

The Drugs Controller General of India has given nod to the Serum Institute of India for conducting phase 2 and 3 human clinical trials of a COVID-19 vaccine candidate, developed by the University of Oxford, in the country. Government officials told PTI that the approval for conducting phase 2 and 3 clinical trials by the SII was granted by DCGI …

India Readies 5 Sites for Final Phase of Human Trials of Oxford-AstraZeneca Covid-19 Vaccine
4 years, 4 months ago

India Readies 5 Sites for Final Phase of Human Trials of Oxford-AstraZeneca Covid-19 Vaccine

News 18  

Five sites across the country are ready for the third and final phase of human trials of the Oxford-AstraZeneca COVID-19 vaccine, Department of Biotechnology Secretary Renu Swarup said on Monday. We have already started working on them and five sites are now ready to be available for Phase 3 trials," Swarup told PTI in a telephonic interview. The Pune-based SII …

Discover Related